SCHEMBL21026032

SCHEMBL21026032

CC(C)CCC1CNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24542650 0.85 LMNA (0.35)
SCHEMBL12784741 0.81 SLC6A1 (0.41)
SCHEMBL4409084 0.81 SLC6A1 (0.41)
SCHEMBL1691629 0.81 SLC6A1 (0.41)
SCHEMBL25206007 0.80
SCHEMBL7893444 0.78 HRH3 (0.41)
SCHEMBL24759565 0.77
SCHEMBL22916041 0.77 HRH3 (0.37)
SCHEMBL21872595 0.75
SCHEMBL104444 0.75 GNAO1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159532-A1 PARATHYROID HORMONE (PTH) RECEPTOR ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2023-05-25 US disclosed
US-11254686-B1 Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor CORVUS PHARMACEUTICALS, INC. (US) 2022-02-22 US disclosed
US-10301253-B2 Therapeutic compounds and uses thereof GENENTECH, INC. (US) 2019-05-28 US disclosed